Bortezomib [clinicaltrials_resource:971de5ed81af535009bbd4354922d911]
intervention [clinicaltrials_vocabulary:intervention]
Bortezomib [clinicaltrials_resource:971de5ed81af535009bbd4354922d911]
Bio2RDF identifier
971de5ed81af535009bbd4354922d911
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:971de5ed81af535009bbd4354922d911
arm group [clinicaltrials_vocabulary:arm-group]
intervention desc [clinicaltrials_vocabulary:intervention-desc]
1.3 mg/m^2 administered intrav ...... followed by 10 day rest period
intervention name [clinicaltrials_vocabulary:intervention-name]
Bortezomib
other name [clinicaltrials_vocabulary:other-name]
identifier
clinicaltrials_resource:971de5ed81af535009bbd4354922d911
title
Bortezomib
@en
type
label
Bortezomib [clinicaltrials_resource:971de5ed81af535009bbd4354922d911]
@en